Drug Profile
Codeine - Hikma Pharmaceuticals
Alternative Names: Codeine sulfate - Hikma PharmaceuticalsLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Roxane Laboratories
- Developer Hikma Pharmaceuticals; Roxane Laboratories; TAGI Pharma
- Class Antitussives; Morphinans; Opioid analgesics
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pain
Most Recent Events
- 06 Jul 2015 The US approved label for codeine sulphate oral solution carries a black box warning